Newstral
Fujifilm Kyowa Kirin Biologics
- GTargeted Drug VEGF Inhibitors for NSCLC Market – Global Outlook and Forecast 2022-2028galleonnews.com
- UBevacizumab Biosimilar Market 2021 Share, Size, Future Demand, Trends, Region by Forecast to 2027| Pfizer, Allergan, Amgen, Bioconunlvrebelyell.com
FDA Defers Decision on Bevacizumab Biosimilarjdsupra.com
Centus Biotherapeutics Receives Positive Opinion for EQUIDACENT (Bevacizumab Biosimilar) in Europejdsupra.com
Biologic and Biosimilar Approval Updatesjdsupra.com
Mylan Partners with Fujifilm Kyowa Kirin Biologicsjdsupra.com
EMA accepts adalimumab biosimilar applications from Fujifilm Kyowa Kirin and Sandoz, and an infliximab biosimilar application from Sandozjdsupra.com
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.